CME Group Senior MD Receives Restricted Stock Grant and Shares Withheld for Taxes

Transaction Analysis: CME Group Inc. ($CME)

Executive Summary

On September 17, 2026, CME Group Inc. reported Form 4 transactions executed by Timothy Francis McCourt, Senior Managing Director, Global Head of Equity & FX Products. The transactions primarily consist of a grant of 2,592 shares of Class A Common Stock under the CME Group Omnibus Stock Plan, coupled with four separate dispositions of shares surrendered to the issuer to cover statutory tax withholding liabilities arising from the vesting of restricted stock.

Transaction Details

• Primary Grant (Code A):
  • Date: September 15, 2026
  • Shares Acquired: 2,592 shares of Class A Common Stock
  • Reference Price: $275.09
  • Total Implied Value: $713,033.28
  • Vesting Terms: Four equal annual installments, subject to continued service.
• Tax Withholdings (Code F):
  • September 15, 2026: 302 shares at $275.09 ($83,077.18)
  • September 15, 2026: 330 shares at $275.09 ($90,779.70)
  • September 15, 2026: 338 shares at $275.09 ($92,980.42)
  • September 16, 2026: 364 shares at $272.46 ($99,175.44)
  • Total Shares Withheld: 1,334 shares ($366,012.74 total tax value)

Ownership Overview

Following these transactions, Mr. McCourt's direct beneficial ownership stands at 13,366 shares of Class A Common Stock.

Market Significance

The trading significance is assessed as Low. These transactions reflect routine equity compensation administration and automatic share withholdings for tax liabilities rather than discretionary open-market purchases or sales.